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Case Report: Bartonella quintana-associated Neuroretinitis
Abstract
Background
Background: Neuroretinitis is a self-limiting condition which typically causes monocular vision loss with
good potential for visual recovery. It may be idiopathic or associated with infectious or inflammatory
conditions which can carry systemic implications. Neuroretinitis classically presents with disc edema
followed by development of a macular star pattern of exudates. It is most commonly attributed to Cat
Scratch Disease, or Bartonella henselae infection. However, there have been few published reports of
Bartonella quintana associated neuroretinitis.
Case Report
Report: A 60-year-old patient presented with unilateral vision loss preceded by flu-like illness. The
patient had exposure to a recently adopted cat. Fundus examination revealed a stellate pattern of
exudates in the macula of the affected eye with questionable sectoral optic disc edema. Serologic testing
revealed a positive titer for Bartonella quintana IgG antibody, but negative Bartonella henselae testing.
This report highlights a rare case of neuroretinitis related to B. quintana infection.
Conclusion
Conclusion: While neuroretinitis is generally considered to be self-limiting, it may be related to a systemic
infection, such as B. henselae and B. quintana. Both B. henselae and B. quintana may present with ocular
findings in the setting of nonspecific systemic symptoms. A thorough ophthalmic examination and
history in conjunction with serologic testing can help to establish a diagnosis and prompt consideration
of further testing or treatment for concurrent systemic disease.
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Introduction
A 60-year-old African American woman presented with a complaint of a “big
patch” over her left eye. She described a constant, stationary dark spot in the center
of her vision that had been present for the past 6 weeks. She denied ocular pain,
flashes, floaters, or transient vision loss. She reported noticing mild, gradual
improvement in her vision over the past few weeks. Ocular history was
unremarkable. Systemic history was remarkable only for hypertension and
hypothyroidism. Systemic medications included amlodipine and levothyroxine.
She had no known drug allergies. She reported excellent compliance with systemic
medications and blood pressure was measured as 140/90mm Hg right arm sitting.
Upon further questioning, she reported suffering from a flu-like illness a few
weeks prior, with frequent headaches, chills, and fatigue. She adopted a cat
approximately one month prior to the onset of her systemic illness. She could not
recall any specific licks, bites, or scratches. She did not seek care for her flu-like
illness or vision earlier because she did not feel well enough to leave her home and
assumed the illness would run its course. At the time of her eye examination, she
reported less frequent headaches and improvement in her fatigue. She was no longer
experiencing any chills or fevers.
Best corrected visual acuities were 20/20 in the right eye and 20/40 in the left eye
with pinhole. She exhibited normal color vision OD and OS by Ishihara and full
visual fields by confrontation in both eyes. There was blur, greater temporally, on
facial Amsler with the left eye. Pupils were isochoric in bright and dim
illuminations. A 0.3 log unit relative afferent pupillary defect (APD) was noted in
the left eye with corresponding 40% subjective red desaturation. Ocular motilities
were full bilaterally. Anterior segment health was remarkable only for trace
bilateral nuclear sclerosis. Her anterior chambers were deep and quiet. Intraocular
pressures were 11mm Hg OU as measured with Goldmann Applanation
Tonometry.
Dilated fundus examination revealed large optic discs with .8/.8 C/D OD and
.75/.75 C/D OS. There was apparent sectoral edema of the inferior temporal aspect
of the left optic disc. The left eye exhibited a partial stellate pattern of exudates in
the macular region (Figure 1).
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Figure 1: Color fundus photograph of the left eye with partial stellate pattern of exudates within
the macular region. Note appearance of inferior temporal optic disc, suspected to be consistent
with likely resolving optic disc edema.

The right eye macula was unremarkable with no exudates (Figure 2).

Figure 2: Color fundus photo of the right eye demonstrating a large optic disc with large cupping
without retinopathy.

Optical coherence tomography (OCT) of the left macula (512x128) revealed
subretinal fluid beneath the fovea, a few subretinal hyperreflective areas, as well as
perifoveal intraretinal exudates nasal to the fovea (Figure 3).
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Figure 3: Cross-section of Macular OCT (512x128) of the left eye demonstrating subretinal fluid
beneath the fovea, hyperreflective areas consistent with exudates primarily in the outer plexiform
layer, and subretinal hyperreflective areas consistent with vitelliform deposits.

The vitreous was clear with no cells in either eye. The retinal arterioles were mildly
attenuated in both eyes. The peripheral retinal examination was unremarkable in
both eyes.
Tentative diagnosis at this time was neuroretinitis based on the presence of an
APD, a macular star, and questionable inferior temporal sectoral disc edema. We
did not have previous records; therefore, we were unable to assess for interval
change in the disc appearance to confirm the presence or absence of optic disc
edema. Regardless, optic nerve involvement was suggested by the presence of the
APD. Differential diagnoses also included branch retinal vein occlusion (BRVO)
and hypertensive retinopathy. The preceding systemic symptoms along with the
lack of retinal hemorrhages or cotton wool spots in either eye made these
differentials less likely.
We recommended prompt lab testing to assess for infectious or inflammatory
causes of neuroretinitis given her preceding flu-like illness. We specifically ordered
Bartonella henselae antibodies with reflex titers, Bartonella quintana antibodies
with reflex titers, Lyme titer, ACE, RPR, FTA-ABS and ANA (see Table 1). In this
case, we chose a targeted work-up and did not test for all potential causes of
neuroretinitis. We specifically left out toxoplasmosis due to the absence of typical
clinical features such as vitritis. We were not highly suspicious of Rocky Mountain
Spotted Fever due to geographic area and presentation during winter months. We
asked the patient to return for follow-up and monitoring in 1 month, or sooner if
she noted any worsening of her vision.
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Etiology

Testing*

Cat-Scratch Disease/ Bartonellosis

Bartonella henselae IgG, IgM
Bartonella quintana IgG, IgM

Lyme Disease

Lyme Titer

Syphilis

FTA-ABS, RPR

Tuberculosis

PPD, Chest X-ray, Quantiferon Gold

Sarcoidosis

ACE, Chest X-ray

Toxoplasmosis

Toxoplasma gondii antibodies

Rocky Mountain Spotted Fever

Rickettsia rickettsii (RMSF IgG)

Leptospirosis

Leptospira IgM

Table 1: Infectious Causes of Neuroretinitis with associated lab testing *Tests may vary by lab

SEROLOGICAL RESULTS
Lab testing results indicated that the B, quintana IgG antibody screen was positive
with a >=1:1024 titer (reference <1:64). B. quintana IgM antibody screen was
negative. Her antibody results were consistent with the reported 6-week duration of
her symptoms. All other lab tests were normal. Her primary care provider was
notified of her ophthalmic presentation and tentative diagnosis. She was also
referred to an infectious disease specialist for consideration of further testing and
treatment.
1 MONTH FOLLOW UP
The patient returned for a one-month re-evaluation with continued subjective
gradual improvement in her vision. She denied any change to her medical history.
She was not on any antibiotic therapy. She had been evaluated by her primary care
provider who discussed her lab results; however, she did not initiate any treatment.
She had not seen an infectious disease specialist as requested. The patient
rescheduled her appointment with the infectious disease specialist to a later date
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and was again educated on the importance of maintaining her appointment.
Blood pressure upon exam measured 127/93mm Hg right arm sitting. Best
corrected visual acuities were 20/20 in both eyes. She exhibited full confrontation
visual fields with normal facial Amsler bilaterally. She no longer reported blur on
facial Amsler in the left eye. Extraocular motility was full in both eyes. She
continued to demonstrate isochoric pupils in bright and dim illuminations. She no
longer exhibited an afferent pupillary defect.
Anterior segment examination was stable and unremarkable. Intraocular pressures
measured with Goldmann Applanation Tonometry were 11mm Hg OD and 12mm
Hg OS.
Dilated fundus examination revealed mild improvement in the density of the
exudates (Figure 4).

Figure 4: Color fundus photograph of the left eye at 1 month follow up showing improvement in
the density of the parafoveal and subfoveal exudates. Optic disc appearance is stable with her
previous visit.

Macular OCT (512x128) also demonstrated resolution of the subretinal fluid
(Figure 5). Given the improvement in her presentation, we again recommended she
return for ocular re-evaluation in 1 month.
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Figure 5: Macular OCT (512x128) showing resolution of subretinal fluid with few residual
intraretinal and subretinal hyperreflective areas.

Unfortunately, despite patient education, she repeatedly rescheduled or no-showed
appointments with the infectious disease specialist. She was, however, compliant
with her ocular re-evaluations and demonstrated clinical resolution after 4 months,
or approximately five and a half months from onset of visual symptoms.
DISCUSSION
Neuroretinitis was initially thought to be a disease of the macula. “Stellate
maculopathy” was first described by Theodor Leber in 1916.1 In 1977, Gass
suggested that the condition was more closely related to a disorder of the optic disc
based on the fact that optic disc edema precedes maculopathy.1 With fluorescein
angiography, he demonstrated that leakage was in fact from the optic disc, further
endorsing his hypothesis. Inflammation leads to leakage of fluid from the optic disc
vasculature into the peripapillary retina. Serial monitoring with OCT has
demonstrated that fluid accumulates within and below the retina as a peripapillary
serous detachment.2 OCT may also show peripapillary or macular retinal
thickening. Over time, as the fluid resorbs, deposits composed of lipid and protein
collect in the outer plexiform layer to produce the characteristic macular star
appearance. These exudates appear as intraretinal hyperreflective foci on OCT.3
Once the exudates have resolved, persistent outer retinal layer disruption (of the
external limiting membrane, ellipsoid zone and the foveal interdigitation zone) may
persist.3
Patients with neuroretinitis typically report painless unilateral loss of vision.
Clinically, patients often demonstrate reduced visual acuity, a small magnitude
relative afferent pupillary defect, and a visual field defect. The pattern of visual
field loss is most commonly a central or cecocentral scotoma. Patients may also
demonstrate blind spot enlargement. The level of vision may be 20/20 to finger
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counting at initial presentation. In some cases, neuroretinitis may be accompanied
by anterior, intermediate, or posterior uveitis.
Disc edema is usually present upon initial examination; however, the classic
macular star appearance develops over a few-week period. The disc edema
typically resolves within three months; however, the macular star persists for a
longer period of time and usually results in slower recovery of visual acuity.4
Depending on the time of presentation, patients may exhibit disc edema and a
macular star or either in isolation. Disc edema in the absence of a macular star
should not exclude neuroretinitis from the list of differential diagnoses.
Neuroretinitis often presents as vision loss following nonspecific systemic
symptoms such as headaches, lymphadenopathy, arthralgia, and rashes particularly
in infectious etiologies. Differential diagnoses of neuroretinitis may include
hypertensive retinopathy, diabetic retinopathy, anterior ischemic optic neuropathy,
retinal vein occlusion or papilledema.
Neuroretinitis may be idiopathic or secondary to infectious or inflammatory
conditions. Infectious etiologies may be due to bacterial, viral, or fungal etiologies
including, but not limited to, Bartonella species, syphilis, Lyme disease,
toxoplasmosis, tuberculosis, West Nile, Zika, histoplasmosis, herpes simplex, and
herpes zoster. Infectious neuroretinitis is more commonly unilateral but may rarely
be bilateral. The presence of bilateral macular stars should raise suspicion for an
alternative etiology such as malignant hypertension or papilledema due to increased
intracranial pressure. Inflammatory conditions, including sarcoidosis, polyarteritis
nodosa and systemic lupus erythematosus may also produce neuroretinitis.5
Idiopathic and recurrent cases of neuroretinitis have also been described. Recurrent
forms of the disease tend to be idiopathic with a poorer visual prognosis. Lack of
preceding systemic symptoms and severe visual field loss tend to be associated with
recurrent disease and less favorable visual prognosis.6 A thorough history inquiring
about concurrent or preceding symptoms such as rashes, animal exposure, fevers,
malaise, and headaches may be helpful in establishing a list of differential
diagnoses and when considering the need for additional serologic testing.
Consideration of geographic location as well as recent travel can be helpful in
developing a thorough, yet targeted, work-up.
Although ocular complications of Bartonella infection are rare, Cat Scratch
Disease, or Bartonella henselae infection, is the most commonly diagnosed cause
of neuroretinitis. Patients exposed to B. henselae may develop a hyperemic papule
at the site of inoculation with development of regional lymphadenopathy over a
period of several weeks. They may later develop a prodromal flu-like illness prior
to onset of visual changes. Five percent of symptomatic patients with B. henselae
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develop Parinaud’s oculoglandular syndrome characterized by unilateral follicular
conjunctivitis with regional lymphadenopathy and possible conjunctival
granulomata.7 This condition is most commonly related to Cat Scratch Disease, but
it can arise secondary to other infectious etiologies and is therefore not
pathognomonic. Only 1-2% of patients with symptomatic B. henselae infection
develop neuroretinitis.7 It is uncommon for patients to present with both
conjunctivitis and neuroretinitis. Pathogenesis of neuroretinitis is thought to be
related to an immune response, intraocular infection, or combination of both.
While B. henselae has a well-documented association with neuroretinitis, B.
quintana is less commonly identified as an etiology with few published case
reports.3 In this case, our patient reported contact with a cat, which initially raised
suspicion for B. henselae and cat-scratch disease. However, it is important to note
that our patient tested positive for B. quintana, not B. henselae. In addition to
neuroretinitis, B. quintana may manifest with other anterior and posterior segment
findings as presented in Table 2.8,9 B. quintana can present similarly to B. henselae,
although B. quintana does not typically produce retinal vascular occlusions,
whereas B. henselae may. Therefore, it is important to consider B. quintana as a
potential etiology in many cases where B. henselae is considered.

Anterior Segment

Posterior Segment

Systemic

Parinaud’s
Oculoglandular
syndrome

Neuroretinitis

Endocarditis

Anterior Uveitis

Retinitis

Trench fever

Vasculitis

Bacillary angiomatosis

Intermediate uveitis

Chronic Bacteremia

Posterior uveitis
Table 2: Manifestations of Bartonella quintana Infection

There are no well-established guidelines for treatment of Bartonella-associated
neuroretinitis. Treatment considerations are often based on case series and
retrospective reviews due to lack of randomized clinical trials. Immunocompetent
patients tend to have favorable visual outcomes given the self-limiting disease
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course, regardless of antibiotic treatment, in both B. henselae and B. quintana
neuroretinitis. Immunocompromised patients or patients with severe systemic
infections may benefit from antibiotic treatment. Treatment with a broad-spectrum
antibiotic may be considered while lab results are pending. Antibiotics such as
doxycycline, rifampin and azithromycin have been reported to reduce the severity
and duration of visual manifestations in neuroretinitis associated with Bartonellosis
(Table 3).9 However, some clinicians recommend treatment only for severe visual
loss or immunocompromised individuals.10 If treatment is to be employed in
pediatric patients, typically azithromycin and/or rifampin are preferred over
doxycycline due to risk of tooth discoloration. Corticosteroids, with or without
antibiotics, may also be considered in the treatment of neuroretinitis, particularly in
cases of severely decreased vision or significant intraocular inflammation. One
study reported better visual outcome with antibiotic plus steroid therapy compared
with antibiotics alone in B. henselae related ocular conditions (including
neuroretinitis as well as uveitis and retinal vascular occlusions).11 Corticosteroids
alone may be considered in cases of recurrent or idiopathic neuroretinitis.
Alternatively, immunosuppressive treatment may be prescribed for patients with
recurrent disease. Ultimately, risk versus benefit of therapy must be weighed due
to possibility of side effects and adverse reactions with pharmacologic therapy. We
elected not to initiate treatment in our patient because she presented non-acutely
with improving visual symptoms.
Antibiotic

Dose (Adult and Children
>45kg)

Dose (Children
<45kg)

Azithromycin

500mg PO for 1 day, then 250mg 10mg/kg PO for 1 day,
PO for 4-6 weeks
then 5mg/kg PO for 46 weeks

Doxycycline22 100mg PO BID for 4-6 weeks

2.2mg/kg BID for 4-6
weeks

Rifampin

10mg/kg BID for 4-6
weeks

300mg PO BID for 4-6 weeks

Table 3: Treatment Options for B. henselae or B.quintana-associated neuroretinitis*
*Duration of treatment may be prolonged in immunocompromised patients

Long-term visual prognosis of Bartonella-associated neuroretinitis is thought to
be quite good. However, there have been reports of poor visual outcomes.
Development of full-thickness macular holes following Bartonella-associated
neuroretinitis have been reported in few case reports.12 A small case series
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published in 1998 found that the majority of patients experienced recovery of visual
acuity and visual fields, although some patients demonstrated persistent fundus
changes such as macular pigmentary abnormalities and disc pallor.13 In the case of
our patient, visual acuity returned to 20/20 and she no longer exhibited an APD at
her one-month follow-up visit without treatment. Four months after her initial
presentation, the retinal exudates had resolved completely. As of her four-month
follow-up, the area concerning for sectoral disc edema in the affected eye persisted.
Bartonella henselae and Bartonella quintana may be diagnosed with serologic
testing; however, there is a potential for false negatives. Acute infections may show
normal titers; if suspicion is high despite normal titers, lab testing may be repeated
after several weeks. There is also cross reactivity between the two organisms,
especially in immunoglobulin G (IgG) titers.14 In most cases, the infecting
organism will have the higher titer. Diagnosis may also be aided by culture,
immunohistochemistry, or polymerase chain reaction (PCR) based testing. High
IgG titers usually indicate active or recent infection while lower titers may indicate
chronic infections.14 Immunoglobulin M (IgM) titers are positive in cases of recent
infection, whereas IgG titers are positive in current or past infection. Ultimately,
the role of the optometrist includes referring the patient to the proper provider(s) to
receive care of non-ocular manifestations. In our case, B. quintana IgG titers were
positive in the setting of normal IgM titers to suggest a more chronic infection. Our
patient had a nonreactive B. henselae titer; therefore, we did not suspect that the B.
quintana titer was a result of cross-reactivity. The patient did not present during the
acute phase of her symptoms. However, since the IgG titer was quite elevated
(>=1:1024), she was promptly referred to an infectious disease specialist for
consideration of further testing for systemic complications such as endocarditis or
chronic bacteremia which would require treatment.
Bartonellosis in humans is most commonly caused by Bartonella henselae, B.
quintana and B. bacillioformis.15 B. henselae is most commonly associated with
ocular manifestations; however, B. quintana has also been implicated in cases of
ocular inflammation including cases of neuroretinitis.3,9 Bartonellosis due to B.
quintana may result in systemic manifestations such as lymphadenopathy,
endocarditis or trench fever.14 Trench fever was named in the early 1900s due to
the high number of illnesses in soldiers in World War I. It is characterized by
recurrent fever, headache, weakness, and bone pain, often in the shins.16
Immunocompromised patients typically have more severe clinical manifestations
of Bartonellosis than patients with normal immune systems; some patients do not
develop any symptoms and many cases are self-limiting within a few months.
Alternatively, some patients develop chronic manifestations including bacteremia,
which may be asymptomatic.
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Both B. henselae and B. quintana may be transmitted to humans via human lice
or cat scratches, licks or bites, or potentially from infected cat fleas or contact with
flea feces. Cats are considered the reservoir for B. henselae while humans are
considered the reservoir for B. quintana. However, both species have been isolated
from cats.17 Cats are not routinely screened for Bartonella. Infected cats may appear
asymptomatic, or may manifest symptoms including fever, lethargy, or vomiting.
Bartonella species are more likely to be transmitted by kittens than by adult cats.
Since both B. henselae and B. quintana have been isolated from cats, it is important
to test for both organisms in cases with history of contact with cats. Homelessness
and living in unsanitary or crowded conditions is also associated with B. quintana
infection which can be transmitted by the human body louse.
It is also important to recognize that treatment may be necessary for other systemic
manifestations. B. quintana has been found to infect erythrocytes and endothelial
cells and can manifest as acute, chronic, or asymptomatic disease states affecting
various organ systems, including the eye.18 There is also a lack of well-established
guidelines for manifestations affecting other organ systems.
Systemic antibiotic therapy for Bartonella infections varies depending on the
systemic manifestations and severity of clinical findings. A systematic review and
meta-analysis from 2012 found no evidence to support a better cure rate or time to
cure with antibiotics for Cat Scratch Disease, or B. henselae infection.18 However,
it is important to note that infections caused by Bartonella species may cause acute
or chronic disease with variable severity and prognosis. More severe manifestations
of infection, such as endocarditis and chronic bacteremia, warrant antibiotic
treatment although there is little consensus on a specific optimal regimen. Given
the wide variety of systemic manifestations and complications, it is important for
the optometrist to co-manage the patient with other providers to assess for
concomitant systemic disease and treat appropriately.
When neuroretinitis is suspected, consider ordering serologic testing for
underlying systemic etiologies. While the ocular condition is considered selflimiting, patients may suffer from systemic consequences as mentioned above. The
presence of ocular findings may be the first indication of systemic manifestations.
An idiopathic recurrent form of neuroretinitis has also been described in which
patients present with more severe visual field defects and less improvement in
visual function. Some patients with recurrent forms of the condition may require
long-term immunosuppression to reduce frequency of attacks.19
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CONCLUSION
This case demonstrates a rare case of B. quintana associated neuroretinitis and
stresses the importance of obtaining a detailed history and using a targeted approach
to diagnosis. While B. henselae is the most common cause of neuroretinitis, it is
important to maintain a thorough list of potential etiologies, including B. quintana,
when considering further serologic testing to improve diagnostic yield. Clinicians
should recognize the potential ocular manifestations of B. quintana and include it
in their work-up along with B. henselae. This case also highlights the importance
of communication and co-management with other providers including primary care
physicians and infectious disease specialists, to ensure that potential systemic
manifestations are addressed.
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